OptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes,
OptiBiotix Health plc (AIM: OPTI) Launch of SlimBiome® in leading US brand
OptiBiotix Health plc (AIM: OPTI), a life sciences company focused on products that reduce hunger and food cravings, improve the gut microbiome, and offer sweet fibres as healthy sugar alternatives,
OptiBiotix Health – SlimBiome® study in European Journal of Nutrition
New SlimBiome® study published in European Journal of Nutrition
OptiBiotix Health jumped 10% in early trading on Tuesday on First order from US News
First order from leading US weight management brand
OptiBiotix Health (AIM:OPTI) reports strong commercial progress for 2024
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes, provides the
OptiBiotix Health (AIM:OPTI) Launch of Daily Nouri FeelFull product in America
Launch of Daily Nouri FeelFull product in America SlimBiome® containing finished products
OptiBiotix Health (AIM:OPTI) Requisition update
OptiBiotix Health plc (AIM: OPTI) (“OptiBiotix”) the life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skincare, advises that in relation to the requisitioned general meeting of
OptiBiotix Health (AIM:OPTI) SlimBiome study update
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skincare, announces further positive study results.
Cellular Goods PLC (LON:CBX) Change of name and Focus on AI Beauty Opportunity
Cellular Goods Plc (LSE: CBX), a company specializing in developing next-generation skincare and wellness products, is pleased to announce that the Company is to change its name to Cel AI PLC. The Company
BSF Enterprise PLC (LON:BSFA) 3D Bio-Tissues Product Partnership Progress
BSF (LSE: BSFA), (OTCQB: BSFAF), the Main Market listed biotech company and owner of pioneering UK-based clinical and cellular agriculture company 3D Bio-Tissues (3DBT), provides an update on the Company’s partnership progress
Integumen PLC (SKIN.L) Rule 2.9 Announcement – update
In accordance with Rule 2.9 of the Code:
Integumen PLC (SKIN.L) RECOMMENDED ALL-EQUITY OFFER FOR MODERN WATER PLC
RECOMMENDED ALL-EQUITY OFFER (“Offer”) for MODERN WATER PLC (“MODERN WATER”) by INTEGUMEN PLC (“INTEGUMEN”)